HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Pemetrexed Disodium and Cisplatin Study Criteria

Read the study criteria about a current clinical trial being conducted to study the effects of pemetrexed disodium and cisplatin for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Study Phase, Type and Design: Phase II Interventional; Treatment, Randomized, Open Label

Official Title: Neoadjuvant Chemotherapy and Extrapleural Pneumonectomy of Malignant Pleural Mesothelioma (MPM) With or Without Hemithoracic Radiotherapy. A Randomized Multicenter Phase II Trial

Primary Outcome Measures:

• Complete macroscopic resection (part 1) [ Designated as safety issue: No ]

• Loco-regional relapse-free survival (part 2) [ Designated as safety issue: No ]

Secondary Outcome Measures:

• Response to neoadjuvant therapy (part 1) [ Designated as safety issue: No ]

• Adverse drug reaction to neoadjuvant therapy (part 1) [ Designated as safety issue: Yes ]

• Operability (part 1) [ Designated as safety issue: No ]

• Surgical complications (part 1) [ Designated as safety issue: No ]

• Reasons for non-randomization (part 1) [ Designated as safety issue: No ]

• Relapse-free or progression-free survival (part 1) [ Designated as safety issue: No ]

• Adverse reaction to postoperative radiotherapy (part 2) [ Designated as safety issue: Yes ]

• Late toxicity (part 2) [ Designated as safety issue: Yes ]

• Feasibility of postoperative radiotherapy (part 2) [ Designated as safety issue: No ]

• Relapse-free survival (part 2) [ Designated as safety issue: No ]

• Psychological distress (quality of life) (part 2) [ Designated as safety issue: No ]

• Overall survival [ Designated as safety issue: No ]

Courtesy of ClinicalTrials.gov.

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Real Stories


Mesothelioma
Mesothelioma Treatments
Treatment
IN THIS SECTION
Antineoplaston therapy for mesothelioma patients
AZD2171 therapy for mesothelioma patients
Current Bortezomib therapy for mesothelioma
Current Dasatinib therapy for mesothelioma
NSC 732517 trial description for mesothelioma
Cisplatin therapy for mesothelioma patients
Current Imatinib therapy for mesothelioma patients
Current Immunotoxin therapy: mesothelioma patients
Early mesothelioma symptoms from Canada asbestos
Canada study criteria of early mesothelioma traits
Contact info for mesothelioma program in Canada
Cisplatin and Pemetrexed therapy for mesothelioma
Description of Pemetrexed mesothelioma study
Inclusion standard in Pemetrexed mesothelioma test
Exclusion standard in Pemetrexed mesothelioma test
Contact info for Pemetrexed mesothelioma study
NGR for mesothelioma
NGR drug trials against mesothelioma
NGR for mesothelioma study
Exclusion criteria for mesothelioma NGR study
Contact for Antineoplaston test on mesothelioma
Pazopanib for mesothelioma patients
Pazopanib for mesothelioma study
Pazopanib inclusion criteria at mesothelioma trial
Patient criteria for mesothelioma Pazopanib study
Pazopanib for mesothelioma therapy
Pemetrexed drug for mesothelioma patients
Pemetrexed drug study for mesothelioma patients
Pemetrexed and cisplatin for mesothelioma patients
Pemetrexed study outline for mesothelioma patients
Pemetrexed disodium drug trial for mesothelioma
Pemetrexed trials for mesothelioma patients
Pemetrexed trials for mesothelioma patients
Contact info: Pemetrexed trial for mesothelioma
Vitamin B12 test on mesothelioma patients
Vitamin B12 study on mesothelioma patients
Outcome of Vitamin B12 on mesothelioma patients
Vitamin B12 outline for mesothelioma study
Patient criteria for B12 study on mesothelioma
Criteria of Vitamin B12 therapy on mesothelioma
Contact info of mesothelioma clinical trial of B12
Novartis LBH589 for mesothelioma
Novartis LBH589 for mesothelioma study
LBH589 trial for mesothelioma
Clinical LBH589 for mesothelioma
Clinical trial for esophageal cancer, mesothelioma
Clinical trial of hTNF for mesothelioma
Valproate for Mesothelioma
Vandetanib tested for mesothelioma
Vorinostat tested for mesothelioma
Avastin therapy for mesothelioma
Carboplatin for MPM mesothelioma patients
Decitabine for mesothelioma
Intravenous CRS-207 for mesothelioma
Sorafenib study on mesothelioma patients
SU011248 for mesothelioma
Temo-Azac combo for mesothelioma
Mesothelioma vaccine GM-CSF
MORAb-009

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Attorney

Asbestos Attorney

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Novartis LBH589 for mesothelioma Clinical trial to study Novartis LBH589 for mesothelioma patients
Read about anti-cancer drug Novartis LBH589 for mesothelioma patients

Contact info: Pemetrexed trial for mesothelioma Contact info for clinical trial of Pemetrexed on mesothelioma patients
Contact info for Pemetrexed trial on mesothelioma victims

Clinical trials for mesothelioma Info about clinical trials on mesothelioma, an asbestos illness
Information on clinical trials of the asbestos illness, mesothelioma